Related Experiment Videos
Hemodynamic characterization of the CarboMedics mitral valve prosthesis
R Bjørnerheim1, H Ihlen, S Simonsen
1Department of Medicine, Rikshospitalet, University of Oslo, Norway.
Insights
The CarboMedics bileaflet mitral valve prosthesis shows excellent hemodynamic function, with significant patient clinical improvement after surgery. Invasive and non-invasive measurements of valve gradients showed strong agreement.
Area of Science:
- Cardiovascular Medicine
- Biomedical Engineering
- Surgical Innovation
Background:
- Mitral valve disease necessitates prosthetic replacement.
- Assessing the hemodynamic performance of prosthetic valves is crucial for patient outcomes.
- The CarboMedics bileaflet mitral valve prosthesis is a common choice for mitral valve replacement.
Purpose of the Study:
- To evaluate the hemodynamic function of the CarboMedics bileaflet mitral valve prosthesis.
- To assess the clinical status of patients before and after mitral valve replacement surgery.
- To compare invasive and non-invasive hemodynamic measurements.
Main Methods:
- Doppler echocardiography in 54 patients six months post-surgery.
- Combined right and left heart catheterization in 22 patients pre- and post-surgery.
- Clinical evaluation using NYHA functional class and hemodynamic parameters.
Main Results:
- Excellent hemodynamic function with small Doppler and invasive mean gradients (3.6 ± 1.2 mmHg and 3.4 ± 1.9 mmHg, respectively).
- No significant difference in gradients across various valve sizes.
- Significant improvement in NYHA class (3.1 to 1.4), normalized pulmonary artery pressure, and improved pulmonary vascular resistance and cardiac index.
- Only physiological regurgitation observed, with no valve dysfunction.
Conclusions:
- The CarboMedics bileaflet mitral valve prosthesis exhibits excellent hemodynamic performance.
- Strong agreement between invasive and non-invasive gradient measurements validates the prosthesis's function.
- Patients experienced substantial clinical improvement, particularly those with prior mitral stenosis.
Background And Aims Of The Study:
The hemodynamic function of the CarboMedics bileaflet mitral valve prosthesis was evaluated by Doppler echocardiography and by heart catheterization. The clinical state of the invasively examined patients was evaluated before and after surgery.
Methods:
Doppler echocardiography was performed in 54 patients at six months after surgery. Further, combined right and left heart catheterization was performed in 22 of these patients before surgery and at six months thereafter.
Results:
The Doppler mean gradients were small (3.6 +/- 1.2 mmHg), and corresponded well with Doppler mean gradients in the subgroup examined with both methods (3.5 +/- 1.1 mmHg) and with the invasive gradients (3.4 +/- 1.9 mmHg); there was also no difference between the different valve sizes. Clinically, pressure recovery distal to the valve is probably so small that no systematic difference between the two techniques of measurement is present. Only physiological regurgitation was found, and no case of valve dysfunction. The patients improved from functional NYHA class 3.1 +/- 0.4 to 1.4 +/- 0.6, regardless of preoperative diagnosis, with most pronounced improvement in those with mitral stenosis. Pulmonary artery pressure was normalized. Pulmonary vascular resistance and cardiac index improved slightly.
Conclusions:
In conclusion, the valvular prostheses demonstrated excellent hemodynamic function. There was striking agreement between the small invasive and non-invasive gradients. Finally, the functional status of the patients improved considerably, most distinctly in those patients with prior mitral stenosis.